Pharmeca.cz

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelants MEDOCHEMIE Ltd, Otsuka Pharmaceutical Netherlands B.V. and Neuraxpharm Bohemia s.r.o., against the decision of the State Institute for Drug Control from 12. 10. 2022, under the no. SUKLS215140/2022:

• the remainder of the appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz.